CpG Oligodeoxynucleotides Inhibit RANKL-Induced Osteoclast Formation by Upregulating A20 Deubiquitinase in RAW 264.7 Cells
Objective. Activation of toll-like receptor 9 (TLR9) has been proposed to play an inhibitory role in RANKL-induced osteoclastogenesis. A20 deubiquitinase has been found to be related to bone loss. This study investigated the role of CpG oligodeoxynucleotides (CpG-ODNs) through regulation of A20 deub...
Saved in:
Main Authors: | Seong-Kyu Kim (Author), Jung-Yoon Choe (Author), Ki-Yeun Park (Author) |
---|---|
Format: | Book |
Published: |
Hindawi Limited,
2022-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
N-Acetyl-l-Leucine-Polyethyleneimine-Mediated Delivery of CpG Oligodeoxynucleotides 2006 Inhibits RAW264.7 Cell Osteoclastogenesis
by: Wang H, et al.
Published: (2020) -
Histone Deacetylase 6 Inhibitor CKD-WID Suppressed Monosodium Urate-Induced Osteoclast Formation by Blocking Calcineurin-NFAT Pathway in RAW 264.7 Cells
by: Seong-Kyu Kim, et al.
Published: (2023) -
CpG Oligodeoxynucleotides for Anticancer Monotherapy from Preclinical Stages to Clinical Trials
by: Zhongkun Zhang, et al.
Published: (2021) -
Co-Encapsulated CpG Oligodeoxynucleotides and Ovalbumin in PLGA Microparticles; An in vitro and in vivo Study
by: Beatriz San Román, et al.
Published: (2014) -
Cooperative activation of human TLR9 and consequences for the clinical development of antisense and CpG oligodeoxynucleotides
by: Gunther Hartmann
Published: (2023)